Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prolactin Receptor Gene Expression and Foetal Adipose Tissue

View through CrossRef
We have investigated the effects of increasing gestational age, maternal undernutrition or restricted placental growth on prolactin receptor (PRLR) gene expression in perirenal adipose tissue collected from foetal sheep during late gestation (term=147 d±3 d of gestation). Foetal nutrient supply was reduced by either restriction of placental growth following removal of endometrial caruncles before mating or by reducing maternal feed intake by 50% from 115 d of gestation. Total RNA was extracted from adipose tissue taken from foetal sheep between 90 and 145 d of gestation, and only at 141–145 d in placentally restricted, nutrient restricted and control foetuses. Messenger RNAs encoding the long (PRLR1) and short (PRLR2) forms of the PRLR and glyceraldehyde‐phosphate‐dehydrogenase (GAPDH) were detected and quantified in a ribonuclease protection assay using an antisense RNA probe complementary to ovine PRLR2 and GAPDH. There was a 7.5‐fold increase in the amount of perirenal adipose tissue between 90 and 125 d of gestation, compared with a 1.3‐fold increase between 125 and 145 d of gestation. The abundance of mRNA encoding PRLR1 and PRLR2 in perirenal adipose tissue increased 10‐ and sixfold, respectively, between 90 and 125 d of gestation, and then declined by 145 d of gestation. Both placental restriction and maternal undernutrition significantly reduced foetal adipose tissue deposition. The abundance of PRLR1 but not PRLR2 mRNA was reduced in adipose tissue from the placentally restricted group, where as GAPDH mRNA was three times higher than in controls. In contrast, maternal undernutrition from 115 d of gestation did not affect PRLR1, PRLR2 or GAPDH mRNA expression in foetal adipose tissue. It is concluded that during the period of rapid deposition of perirenal adipose tissue, there is a concomitant increase in PRLR gene expression. This indicates that prolactin may play an important role in the growth and maturation of foetal adipose tissue which occurs before birth.
Title: Prolactin Receptor Gene Expression and Foetal Adipose Tissue
Description:
We have investigated the effects of increasing gestational age, maternal undernutrition or restricted placental growth on prolactin receptor (PRLR) gene expression in perirenal adipose tissue collected from foetal sheep during late gestation (term=147 d±3 d of gestation).
Foetal nutrient supply was reduced by either restriction of placental growth following removal of endometrial caruncles before mating or by reducing maternal feed intake by 50% from 115 d of gestation.
Total RNA was extracted from adipose tissue taken from foetal sheep between 90 and 145 d of gestation, and only at 141–145 d in placentally restricted, nutrient restricted and control foetuses.
Messenger RNAs encoding the long (PRLR1) and short (PRLR2) forms of the PRLR and glyceraldehyde‐phosphate‐dehydrogenase (GAPDH) were detected and quantified in a ribonuclease protection assay using an antisense RNA probe complementary to ovine PRLR2 and GAPDH.
There was a 7.
5‐fold increase in the amount of perirenal adipose tissue between 90 and 125 d of gestation, compared with a 1.
3‐fold increase between 125 and 145 d of gestation.
The abundance of mRNA encoding PRLR1 and PRLR2 in perirenal adipose tissue increased 10‐ and sixfold, respectively, between 90 and 125 d of gestation, and then declined by 145 d of gestation.
Both placental restriction and maternal undernutrition significantly reduced foetal adipose tissue deposition.
The abundance of PRLR1 but not PRLR2 mRNA was reduced in adipose tissue from the placentally restricted group, where as GAPDH mRNA was three times higher than in controls.
In contrast, maternal undernutrition from 115 d of gestation did not affect PRLR1, PRLR2 or GAPDH mRNA expression in foetal adipose tissue.
It is concluded that during the period of rapid deposition of perirenal adipose tissue, there is a concomitant increase in PRLR gene expression.
This indicates that prolactin may play an important role in the growth and maturation of foetal adipose tissue which occurs before birth.

Related Results

Prolactin binding by testes of unilaterally cryptorchid rats: the effect of hCG, testosterone, prolactin and orchiopexy
Prolactin binding by testes of unilaterally cryptorchid rats: the effect of hCG, testosterone, prolactin and orchiopexy
Abstract. The effect of unilateral cryptorchidism on prolactin binding to the testes was studied in the rat. Cryptorchidism was rendered surgically for 3 weeks and 3, 6 and 9 weeks...
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Background and Objective. Obesity promotes endothelial dysfunction, a major contributor to the development of cardiovascular disease. Work from our lab and others previously showed...
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
Objective Study the clinical efficacy and safety of transplacental digoxin therapy for foetal heart failure. Investigate the evaluation and treatment guiding valu...
Differential regulation of the expression of α1-adrenergic receptor subtype genes in brown adipose tissue
Differential regulation of the expression of α1-adrenergic receptor subtype genes in brown adipose tissue
The physiological control of the expression of the genes for the α1-adrenoceptor subtypes was examined in rat brown adipose tissue by analysing Northern blots of poly(A)-enriched R...
Abstract 528: Characterization of Δ7/11, a functional prolactin-binding protein.
Abstract 528: Characterization of Δ7/11, a functional prolactin-binding protein.
Abstract Prolactin is essential for normal mammary gland development and differentiation, and has been shown to promote tumor cell proliferation and chemotherapeutic...

Back to Top